144 related articles for article (PubMed ID: 18630474)
21. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
[TBL] [Abstract][Full Text] [Related]
22. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas.
Gakiopoulou H; Nakopoulou L; Siatelis A; Mavrommatis I; Panayotopoulou EG; Tsirmpa I; Stravodimos C; Giannopoulos A
Clin Cancer Res; 2003 Nov; 9(15):5573-81. PubMed ID: 14654538
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
[TBL] [Abstract][Full Text] [Related]
24. [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis].
Wang L; Zhang LH; Li YL; Li YL; Liu Z
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):782-6. PubMed ID: 12899759
[TBL] [Abstract][Full Text] [Related]
25. [Molecular biology studies on metalloproteinase and tissue inhibitor of metalloproteinase expression in salivary adenoid cystic carcinoma].
Shi H; He R; Zhou X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Nov; 32(6):323-6. PubMed ID: 11189300
[TBL] [Abstract][Full Text] [Related]
26. Detection of serum MMPs in tumor-bearing hamsters.
Iki K; Takeo T; Kubozoe T; Aoki S; Hayashi J; Tsunoda T
J Hepatobiliary Pancreat Surg; 2002; 9(4):478-84. PubMed ID: 12483270
[TBL] [Abstract][Full Text] [Related]
27. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
[TBL] [Abstract][Full Text] [Related]
28. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
29. The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.
Xiao M; Zhou NX; Huang ZQ; Lu YL; Chen LH; Wang DJ; Chang WL
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):599-602. PubMed ID: 15567754
[TBL] [Abstract][Full Text] [Related]
30. Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit.
Mandic R; Dünne AA; Eikelkamp N; Ramaswamy A; Schulz S; Teymoortash A; Sesterhenn A; Moll R; Werner JA
Anticancer Res; 2002; 22(6A):3281-4. PubMed ID: 12530076
[TBL] [Abstract][Full Text] [Related]
31. [Matrix metalloproteinase-2 and angiogenesis in gastric cancer].
Cai H; Kong ZR; Chen HM
Ai Zheng; 2002 Jan; 21(1):25-8. PubMed ID: 12500392
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma.
Stipa F; Lucandri G; Limiti MR; Bartolucci P; Cavallini M; Di Carlo V; D'Amato A; Ribotta G; Stipa S
Anticancer Res; 2002; 22(1A):445-9. PubMed ID: 12017330
[TBL] [Abstract][Full Text] [Related]
33. Neovascularization in pancreatic ductal adenocarcinoma: Microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas.
Ueda T; Oda T; Kinoshita T; Konishi M; Nakahashi C; Takahashi S; Hasebe T; Fukao K; Ochiai A
Oncol Rep; 2002; 9(2):239-45. PubMed ID: 11836587
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.
Ross JS; Kaur P; Sheehan CE; Fisher HA; Kaufman RA; Kallakury BV
Mod Pathol; 2003 Mar; 16(3):198-205. PubMed ID: 12640098
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
Zhang Y; Wu XH; Cao GH; Li S
Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
[TBL] [Abstract][Full Text] [Related]
37. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Guttman D; Stern Y; Shpitzer T; Ulanovski D; Druzd T; Feinmesser R
Oral Oncol; 2004 Sep; 40(8):798-803. PubMed ID: 15288834
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):71-6. PubMed ID: 11286133
[TBL] [Abstract][Full Text] [Related]
39. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
40. [Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors].
Xu Y; Chen M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 18(9):542-4. PubMed ID: 15696952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
